Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
Eagle Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Eagle Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, five executives at Eagle Pharmaceuticals received on average a compensation package of $4.4M, a 30% increase compared to previous year.
Average pay of disclosed executives at Eagle Pharmaceuticals
Scott Tarriff, Chief Executive Officer, received $11M in total, which increased by 41% compared to 2017. 50% of Tarriff's compensation, or $5.7M, was in stock awards. Tarriff also received $654K in non-equity incentive plan, $4.2M in option awards, $769K in salary, as well as $19K in other compensation.
For fiscal year 2018, the median employee pay was $236,618 at Eagle Pharmaceuticals. Therefore, the ratio of Scott Tarriff's pay to the median employee pay was 48 to one.
David Pernock, Chief Operating Officer, received a compensation package of $3.7M, which decreased by 2% compared to previous year. 41% of the compensation package, or $1.5M, was in stock awards.
Adrian J. Hepner, Chief Medical Officer, earned $3.1M in 2018, a 11% increase compared to previous year.
Pete A. Meyers, Chief Financial Officer, received $2.7M in 2018, which increases by 41% compared to 2017.
Steven L. Krill, Chief Scientific Officer, earned $1.1M in 2018, a 43% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.